Alterola Biotech, Inc.
ABTI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $37 | $9 | $13 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | -$9 | -$37 | $38 | $35 |
| Inventory | $1 | $1 | $1 | $1 |
| Other Curr. Assets | $196 | $230 | $189 | $44 |
| Total Curr. Assets | $197 | $231 | $237 | $192 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $300 | $12,462 | $12,140 | $12,018 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $187 | $194 | $189 | $143 |
| Other NC Assets | -$187 | -$194 | -$189 | -$143 |
| Total NC Assets | $300 | $12,462 | $12,140 | $12,018 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $497 | $12,693 | $12,377 | $12,210 |
| Liabilities | – | – | – | – |
| Payables | $722 | $678 | $612 | $669 |
| Short-Term Debt | $1,551 | $1,373 | $1,260 | $1,142 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | -$1,551 | -$1,373 | $0 | $0 |
| Other Curr. Liab. | -$476 | $978 | -$357 | -$656 |
| Total Curr. Liab. | $2,519 | $2,334 | $2,127 | $1,823 |
| LT Debt | $0 | $0 | $154 | $151 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | -$0 |
| Total NC Liab. | $0 | $0 | $154 | $151 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,519 | $2,334 | $2,281 | $1,974 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $10 | $0 | $0 |
| Common Stock | $778 | $807 | $807 | $807 |
| Retained Earnings | -$10,431 | -$10,295 | -$9,576 | -$9,556 |
| AOCI | $21 | -$10 | -$63 | $58 |
| Other Equity | $7,610 | $19,847 | $18,928 | $18,928 |
| Total Equity | -$2,022 | $10,359 | $10,096 | $10,236 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $497 | $12,693 | $12,377 | $12,210 |
| Net Debt | $1,542 | $1,336 | $1,406 | $1,280 |